• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例间充质肩胛骨分泌成纤维细胞生长因子肿瘤的病例报告:肿瘤诱导性骨软化症随访的重要性

A case report of mesenchymal scapular FGF secreting tumor: Importance of follow up in tumor induced osteomalacia.

作者信息

Shrivastava Trilok, Hwang Jessica L, Munshi Laishiya, Batra Kumar Kunnal, Ahuja Kriti

机构信息

John H. Stroger Hospital of Cook County, Chicago, IL, USA.

Rush University Medical Center, Chicago, IL, USA.

出版信息

Radiol Case Rep. 2021 Feb 17;16(4):989-993. doi: 10.1016/j.radcr.2021.02.002. eCollection 2021 Apr.

DOI:10.1016/j.radcr.2021.02.002
PMID:33664928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7900011/
Abstract

A 46-year-old Asian male with history of atraumatic fracture of femur (requiring the use of a walker), muscle cramps and loosening teeth presents to Endocrine clinic. He had elevated parathyroid hormone, severely low phosphorus, elevated bone-specific ALP, with normal serum and urine calcium. He was found to have elevated FGF 23 levels, but initial functional and anatomic imaging was negative for any localizing tumor. With persistent follow-up and serial imaging, after 3 years, a 2.2 cm right scapular mass was found on MRI. Since it was also visualized on PET/CT, this was suspected to be the cause of his severe hypophosphatemia. He underwent surgical excision and pathology revealed a phosphaturic mesenchymal tumor after excision. Tumor induced osteomalacia is a rare, acquired paraneoplastic syndrome in which a tumor that secretes FGF23 leads to decreased renal phosphate reabsorption, resulting in hypophosphatemia, and bone demineralization. Diagnosis is challenging as common presenting symptoms are nonspecific, but when followed up closely with proper diagnostic modalities, identification & removal of the culprit lesion is usually curative.

摘要

一名46岁的亚洲男性,有非创伤性股骨骨折病史(需要使用助行器)、肌肉痉挛和牙齿松动,前来内分泌诊所就诊。他的甲状旁腺激素升高,磷严重降低,骨特异性碱性磷酸酶升高,血清和尿钙正常。发现他的成纤维细胞生长因子23(FGF 23)水平升高,但最初的功能和解剖成像未发现任何定位肿瘤。经过持续随访和系列成像,3年后,磁共振成像(MRI)发现右肩胛骨有一个2.2厘米的肿块。由于在正电子发射断层显像/X线计算机体层成像(PET/CT)上也能看到,怀疑这是他严重低磷血症的原因。他接受了手术切除,术后病理显示为切除性磷尿性间叶肿瘤。肿瘤性骨软化症是一种罕见的获得性副肿瘤综合征,其中分泌FGF23的肿瘤导致肾磷酸盐重吸收减少,从而导致低磷血症和骨质脱矿。由于常见的症状不具特异性,诊断具有挑战性,但通过适当的诊断方法密切随访时,识别并切除罪魁祸首病变通常可治愈。

相似文献

1
A case report of mesenchymal scapular FGF secreting tumor: Importance of follow up in tumor induced osteomalacia.一例间充质肩胛骨分泌成纤维细胞生长因子肿瘤的病例报告:肿瘤诱导性骨软化症随访的重要性
Radiol Case Rep. 2021 Feb 17;16(4):989-993. doi: 10.1016/j.radcr.2021.02.002. eCollection 2021 Apr.
2
Tumor-Induced Osteomalacia With Normal Fibroblast Growth Factor-23 (FGF23) and Idiopathic Hypercalciuria.伴有正常成纤维细胞生长因子23(FGF23)的肿瘤性骨软化症与特发性高钙尿症。
Cureus. 2022 Jan 3;14(1):e20893. doi: 10.7759/cureus.20893. eCollection 2022 Jan.
3
Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.经影像引导消融治疗引起骨软化症的持续性磷质间叶性肿瘤。
Osteoporos Int. 2021 Sep;32(9):1895-1898. doi: 10.1007/s00198-020-05795-1. Epub 2021 Mar 2.
4
Renal Phosphate Wasting Due to Tumor-Induced (Oncogenic) Osteomalacia.肿瘤诱导(致癌性)骨软化症导致的肾性磷酸盐消耗
Cureus. 2021 Jun 7;13(6):e15507. doi: 10.7759/cureus.15507. eCollection 2021 Jun.
5
A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.一例罕见的沿腱鞘多发磷尿性间叶肿瘤致骨软化症病例。
BMC Musculoskelet Disord. 2017 Feb 13;18(1):79. doi: 10.1186/s12891-017-1446-z.
6
Tumor-induced osteomalacia.肿瘤诱导的骨软化症。
Bone Rep. 2017 Sep 20;7:90-97. doi: 10.1016/j.bonr.2017.09.002. eCollection 2017 Dec.
7
Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia - diagnostic challenges and clinical outcomes.股骨皮质隐匿性磷酸盐尿性间叶性肿瘤致瘤性骨软化症——诊断挑战与临床结局。
Endokrynol Pol. 2018;69(2):205-210. doi: 10.5603/EP.a2018.0016. Epub 2018 Feb 14.
8
Fibroblast Growth Factor 23-Producing Phosphaturic Mesenchymal Tumor with Extraordinary Morphology Causing Oncogenic Osteomalacia.成纤维细胞生长因子 23 分泌性磷酸尿素质瘤伴奇异形态导致的瘤源性骨软化症。
Medicina (Kaunas). 2020 Jan 16;56(1):34. doi: 10.3390/medicina56010034.
9
Cinacalcet in the management of tumor-induced osteomalacia.西那卡塞在肿瘤诱导性骨软化症治疗中的应用
J Bone Miner Res. 2007 Jun;22(6):931-7. doi: 10.1359/jbmr.070304.
10
Reports of 17 Chinese patients with tumor-induced osteomalacia.17例肿瘤诱导性骨软化症中国患者的报告。
J Bone Miner Metab. 2017 May;35(3):298-307. doi: 10.1007/s00774-016-0756-9. Epub 2016 Apr 16.

引用本文的文献

1
Tumor induced osteomalacia - A long way toward correct diagnosis and management.肿瘤诱导性骨软化症——迈向正确诊断与治疗的漫长之路。
Bone Rep. 2022 Mar 8;16:101180. doi: 10.1016/j.bonr.2022.101180. eCollection 2022 Jun.

本文引用的文献

1
Tumor-induced osteomalacia.肿瘤诱导的骨软化症
Osteoporos Sarcopenia. 2018 Dec;4(4):119-127. doi: 10.1016/j.afos.2018.12.001. Epub 2018 Dec 12.
2
Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.与磷尿性间叶肿瘤相关的肿瘤性骨软化症的治疗及预后:12例患者的回顾性分析
BMC Musculoskelet Disord. 2017 Sep 21;18(1):403. doi: 10.1186/s12891-017-1756-1.
3
Oncogenic osteomalacia: role of Ga-68 DOTANOC PET/CT scan in identifying the culprit lesion and its management.
致癌性骨软化症:Ga-68 DOTANOC PET/CT扫描在识别罪魁祸首病变及其管理中的作用。
Br J Radiol. 2017 Apr;90(1072):20160811. doi: 10.1259/bjr.20160811. Epub 2017 Feb 9.
4
Ga-DOTATATE for Tumor Localization in Tumor-Induced Osteomalacia.镓-多柔比星用于肿瘤性骨软化症的肿瘤定位
J Clin Endocrinol Metab. 2016 Oct;101(10):3575-3581. doi: 10.1210/jc.2016-2052. Epub 2016 Aug 17.
5
Hypophosphatemic osteomalacia in von Recklinghausen neurofibromatosis: Case report and literature review.冯雷克林霍增氏神经纤维瘤病中的低磷性骨软化症:病例报告及文献综述
Indian J Radiol Imaging. 2015 Jan-Mar;25(1):63-6. doi: 10.4103/0971-3026.150155.
6
Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.HRAS 和 NRAS 中的多谱系体细胞激活突变导致镶嵌性皮肤和骨骼病变、FGF23 升高和低磷血症。
Hum Mol Genet. 2014 Jan 15;23(2):397-407. doi: 10.1093/hmg/ddt429. Epub 2013 Sep 4.
7
Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.肿瘤诱导的骨软化合并成纤维细胞生长因子23升高:1例伴结缔组织变异型的磷尿性间叶肿瘤病例及文献复习
Chin J Cancer. 2011 Nov;30(11):794-804. doi: 10.5732/cjc.011.10013.
8
Tumor-induced osteomalacia (TIO): atypical presentation.肿瘤诱导的骨软化症(TIO):非典型表现。
South Med J. 2011 May;104(5):348-50. doi: 10.1097/SMJ.0b013e31821427db.
9
Tumor-induced osteomalacia.肿瘤相关性骨软化症。
Endocr Relat Cancer. 2011 Jun 8;18(3):R53-77. doi: 10.1530/ERC-11-0006. Print 2011 Jun.
10
Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia.生长抑素受体闪烁扫描术在肿瘤诱导性骨软化症治疗中的临床影响
Clin Nucl Med. 2008 Nov;33(11):752-6. doi: 10.1097/RLU.0b013e31818866bf.